Session » Osteoarthritis – Clinical Poster II

Date: Monday, October 22, 2018

Time: 9:00AM-11:00AM

Meeting: 2018 ACR/ARHP Annual Meeting

9:00AM-11:00AM: Abstract Number: 1359

A Machine Learning Approach to Knee OA Phenotyping: The Johnston County Osteoarthritis Project

9:00AM-11:00AM: Abstract Number: 1365

A Phase IIa Study of Anti-GM-CSF Antibody GSK3196165 in Subjects with Inflammatory Hand Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1372

An Analysis of the Quality and Readability of Online Osteoarthritis Information with Historical Comparison

9:00AM-11:00AM: Abstract Number: 1366

Assessment of Health-Related Quality of Life in a 52-Week, Phase 2, Randomized, Controlled Trial of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for Treatment of Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1355

Asymptomatic Hyperuricemia Is Associated with Increased Prevalence of Symptomatic Knee Osteoarthritis: Data from Third National Health and Nutrition Examination Survey

9:00AM-11:00AM: Abstract Number: 1375

Comparative Safety of Flavocoxid (Limbrel) Versus Nsaids Among Osteoarthritis Patients

9:00AM-11:00AM: Abstract Number: 1354

Correlates of Neuropathic Pain in Knee Osteoarthritis: The Modified Paindetect Questionnaire and the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 1370

Detection of an Autoantibody Profile to Characterize Patients with Early (Pre-symptomatic) Knee Osteoarthritis: Data from the Osteoarthritis Initiative

9:00AM-11:00AM: Abstract Number: 1368

Diabetes Mellitus Is Not a Risk Factor for Knee Osteoarthritis, a Systematic Review and Meta-Analysis

9:00AM-11:00AM: Abstract Number: 1367

Efficacy of Intra-Articular Cntx-4975 for Knee OA Pain Varies with Radiographic Presence of OA in the Opposite Knee

9:00AM-11:00AM: Abstract Number: 1357

Flexion Contractures Are Associated with Worse Pain, Stiffness, and Function in Patients with Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1356

Increasing Oral Doses of GLPG1972 Administered Daily for 29 Days Show a Strong Target Engagement in Patients with Knee and/or Hip OA

9:00AM-11:00AM: Abstract Number: 1377

Knee Osteoarthritis Symptom Duration Is Associated with Conditioned Pain Modulation and Vibration Perception Threshold Impairment

9:00AM-11:00AM: Abstract Number: 1362

Magnetic Resonance Imaging Features Can Classify Adults Who Will Develop Accelerated Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1361

Predictive Modeling of Therapeutic Response in Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1373

Predictive Probabilities Are Superior in Communicating the Clinical Relevance of Cartilage Thickness As an Imaging Biomarker of Knee Osteoarthritis Progression

9:00AM-11:00AM: Abstract Number: 1363

Progression of Pain, Stiffness, Function Changes, and Ultrasound Detected Synovitis and Osteophyte Formation in Patients with Hand Osteoarthritis over Three Years

9:00AM-11:00AM: Abstract Number: 1371

Systemic Exposure of Triamcinolone Acetonide Following Bilateral Injection of Extended-Release Triamcinolone Acetonide and Standard Triamcinolone in Patients with Bilateral Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1358

The Association of Microbial Translocation and WOMAC Function in Patients with Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1369

The Influence of Hand Osteoarthritis on Bone Microstructure and Biomechanical Properties of Radial Bone

9:00AM-11:00AM: Abstract Number: 1376

The Omeract-Oarsi Core Set of Outcome Domains to Measure in Clinical Trials for People with Hip and/or Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1374

The Relationship between Loneliness and Osteoarthritis in US Adults from a Nationally Representative Survey

9:00AM-11:00AM: Abstract Number: 1360

The Role of Personality in Patients with Knee Osteoarthritis

9:00AM-11:00AM: Abstract Number: 1364

Treatment of Knee Osteoarthritis with SM04690 Improved WOMAC A1 “Pain on Walking” – Results from a 52-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of a Novel, Intra-Articular, Wnt Pathway Inhibitor

9:00AM-11:00AM: Abstract Number: 1378

Validation of a Spanish Version of the Functional Index for Hand Osteoarthritis (FIHOA)

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].